Dupuytren Contracture: Differential Diagnoses & Workup

References

1. Augoff K, Tabola R, Kula J, Gosk J, Rutowski R. Epidermal growth factor receptor (EGF-R) in Dupuytren's disease. J Hand Surg [Br]. Dec 2005;30(6):570-3. [Medline].

2. Johnston P, Chojnowski AJ, Davidson RK, Riley GP, Donell ST, Clark IM. A complete expression profile of matrix-degrading metalloproteinases in Dupuytren's disease. J Hand Surg [Am]. Mar 2007;32(3):343-51. [Medline].

3. Ulrich D, Ulrich F, Piatkowski A, Pallua N. Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease. Arch Orthop Trauma Surg. Aug 30 2008;[Medline].

4. Kopp J, Seyhan H, Muller B, Lanczak J, Pausch E, Gressner AM. N-acetyl-L-cysteine abrogates fibrogenic properties of fibroblasts isolated from Dupuytren's disease by blunting TGF-beta signalling. J Cell Mol Med. Jan-Mar 2006;10(1):157-65. [Medline].

5. Forsman M, Paakkonen V, Tjaderhane L, Vuoristo J, Kallioinen L, Salo T. The expression of myoglobin and ROR2 protein in Dupuytren's disease. J Surg Res. May 15 2008;146(2):271-5. [Medline].

6. Gonzalez MH, Sobeski J, Grindel S, Chunprapaph B, Weinzweig N. Dupuytren's disease in African-Americans. J Hand Surg [Br]. Jun 1998;23(3):306-7. [Medline].

7. Bebbington A, Savage R. Dupuytren's disease in an infant. J Bone Joint Surg Br. Jan 2005;87(1):111-3. [Medline].

8. Wilbrand S, Ekbom A, Gerdin B. The sex ratio and rate of reoperation for Dupuytren's contracture in men and women. J Hand Surg [Br]. Aug 1999;24(4):456-9. [Medline].

9. Habash A, Rinker B. Dupuytren's disease involving the wrist. J Hand Surg [Am]. Mar 2007;32(3):352-4. [Medline].

10. Meathrel KE, Thoma A. Abductor digiti minimi involvement in Dupuytren's contracture of the small finger. J Hand Surg [Am]. May 2004;29(3):510-3. [Medline].

11. Burge P. Genetics of Dupuytren's disease. Hand Clin. Feb 1999;15(1):63-71. [Medline].

12. Hindocha S, John S, Stanley JK, Watson SJ, Bayat A. The heritability of Dupuytren's disease: familial aggregation and its clinical significance. J Hand Surg [Am]. Feb 2006;31(2):204-10. [Medline].

13. Lee LC, Zhang AY, Chong AK, Pham H, Longaker MT, Chang J. Expression of a novel gene, MafB, in Dupuytren's disease. J Hand Surg [Am]. Feb 2006;31(2):211-8. [Medline].

14. Hu FZ, Nystrom A, Ahmed A, et al. Mapping of an autosomal dominant gene for Dupuytren's contracture to chromosome 16q in a Swedish family. Clin Genet. Nov 2005;68(5):424-9. [Medline].

15. Bayat A, Walter J, Lambe H, et al. Identification of a novel mitochondrial mutation in Dupuytren's disease using multiplex DHPLC. Plast Reconstr Surg. Jan 2005;115(1):134-41. [Medline].

16. Gudmundsson KG, Arngrimsson R, Jonsson T. Dupuytren's disease, alcohol consumption and alcoholism. Scand J Prim Health Care. Sep 2001;19(3):186-90. [Medline].

17. Brown JJ, Ollier W, Thomson W, Bayat A. Positive association of HLA-DRB1*15 with Dupuytren's disease in Caucasians. Tissue Antigens. Aug 2008;72(2):166-70. [Medline].

18. Kuhn MA, Wang X, Payne WG, Ko F, Robson MC. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia. J Surg Res. Apr 2002;103(2):146-52. [Medline].

19. Pagnotta A, Specchia N, Soccetti A, Manzotti S, Greco F. Responsiveness of Dupuytren's disease fibroblasts to 5 alpha-dihydrotestosterone. J Hand Surg [Am]. Nov 2003;28(6):1029-34. [Medline].

20. Yildiz S, Karacaoglu E, Pehlivan O. Hyperbaric oxygen for the treatment of early-phase Dupuytren's contracture. Microsurgery. 2004;24(1):26-9. [Medline].

21. Ketchum LD, Donahue TK. The injection of nodules of Dupuytren's disease with triamcinolone acetonide. J Hand Surg [Am]. Nov 2000;25(6):1157-62. [Medline].

22. Badalamente MA, Hurst LC, Hentz VR. Collagen as a clinical target: nonoperative treatment of Dupuytren's disease. J Hand Surg [Am]. Sep 2002;27(5):788-98. [Medline].

23. Hurst LC, Badalamente MA. Nonoperative treatment of Dupuytren's disease. Hand Clin. Feb 1999;15(1):97-107, vii. [Medline].

24. Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. J Hand Surg [Am]. Jul-Aug 2007;32(6):767-74. [Medline].

25. Townley WA, Cambrey AD, Khaw PT, Grobbelaar AO. Matrix metalloproteinase inhibition reduces contraction by dupuytren fibroblasts. J Hand Surg [Am]. Nov 2008;33(9):1608-16. [Medline].

26. Bulstrode NW, Mudera V, McGrouther DA, Grobbelaar AO, Cambrey AD. 5-fluorouracil selectively inhibits collagen synthesis. Plast Reconstr Surg. Jul 2005;116(1):209-21; discussion 222-3. [Medline].

27. Jemec B, Linge C, Grobbelaar AO, Smith PJ, Sanders R, McGrouther DA. The effect of 5-fluorouracil on Dupuytren fibroblast proliferation and differentiation. Chir Main. Feb 2000;19(1):15-22. [Medline].

28. Namazi H. Imiquimod: a potential weapon against Dupuytren contracture. Med Hypotheses. 2006;66(5):991-2. [Medline].

29. Namazi H, Abdinejad F. Botulinum Toxin as a novel addition to the antidupuytren armamentarium. Med Hypotheses. 2007;68(1):240-1. [Medline].

30. Skoff HD. The surgical treatment of Dupuytren's contracture: a synthesis of techniques. Plast Reconstr Surg. Feb 2004;113(2):540-4. [Medline].

31. Zyluk A, Jagielski W. The effect of the severity of the Dupuytren's contracture on the function of the hand before and after surgery. J Hand Surg Eur Vol. Jun 2007;32(3):326-9. [Medline].

32. Hogemann A, Wolfhard U, Kendoff D, Board TN, Olivier LC. Results of total aponeurectomy for Dupuytren's contracture in 61 patients: a retrospective clinical study. Arch Orthop Trauma Surg. May 31 2008;[Medline].

33. Ali SN, McMurtrie A, Rayatt S, Roberts JO. Ulnar-based skin flap for Dupuytren's fasciectomy. Scand J Plast Reconstr Surg Hand Surg. 2006;40(5):307-10. [Medline].

34. Pelissier P, Gardet H, Pinsolle V. The palmar intermetacarpal flap in Dupuytren's contracture. J Hand Surg Eur Vol. Feb 2007;32(1):113. [Medline].

35. Tripoli M, Merle M. The "Jacobsen Flap" for the Treatment of Stages III-IV Dupuytren's Disease: A Review of 98 Cases. J Hand Surg Eur Vol. Dec 2008;33(6):779-82. [Medline].

36. van Rijssen AL, Werker PM. Percutaneous needle fasciotomy in dupuytren's disease. J Hand Surg [Br]. Oct 2006;31(5):498-501. [Medline].

37. van Rijssen AL, Gerbrandy FS, Ter Linden H, Klip H, Werker PM. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study. J Hand Surg [Am]. May-Jun 2006;31(5):717-25. [Medline].

38. Cheng HS, Hung LK, Tse WL, Ho PC. Needle aponeurotomy for Dupuytren's contracture. J Orthop Surg (Hong Kong). Apr 2008;16(1):88-90. [Medline].

39. Jerosch-Herold C, Shepstone L, Chojnowski AJ, Larson D. Splinting after contracture release for Dupuytren's contracture (SCoRD): protocol of a pragmatic, multi-centre, randomized controlled trial. BMC Musculoskelet Disord. Apr 30 2008;9:62. [Medline].

40. Evans RB, Dell PC, Fiolkowski P. A clinical report of the effect of mechanical stress on functional results after fasciectomy for Dupuytren's contracture. J Hand Ther. Oct-Dec 2002;15(4):331-9. [Medline].

41. Misra A, Jain A, Ghazanfar R, Johnston T, Nanchahal J. Predicting the outcome of surgery for the proximal interphalangeal joint in Dupuytren's disease. J Hand Surg [Am]. Feb 2007;32(2):240-5. [Medline].

42. Symes T, Stothard J. Two significant complications following percutaneous needle fasciotomy in a patient on anticoagulants. J Hand Surg [Br]. Dec 2006;31(6):606-7. [Medline].

43. Reuben SS, Pristas R, Dixon D, Faruqi S, Madabhushi L, Wenner S. The incidence of complex regional pain syndrome after fasciectomy for Dupuytren's contracture: a prospective observational study of four anesthetic techniques. Anesth Analg. Feb 2006;102(2):499-503. [Medline].

44. Abe Y, Rokkaku T, Ofuchi S, Tokunaga S, Takahashi K, Moriya H. An objective method to evaluate the risk of recurrence and extension of Dupuytren's disease. J Hand Surg [Br]. Oct 2004;29(5):427-30. [Medline].

45. Al-Qattan MM. Factors in the pathogenesis of Dupuytren's contracture. J Hand Surg [Am]. Nov 2006;31(9):1527-34. [Medline].

46. Benson LS, Williams CS, Kahle M. Dupuytren's contracture. J Am Acad Orthop Surg. Jan-Feb 1998;6(1):24-35. [Medline].

47. Bulstrode NW, Jemec B, Smith PJ. The complications of Dupuytren's contracture surgery. J Hand Surg [Am]. Sep 2005;30(5):1021-5. [Medline].

48. Draviaraj KP, Chakrabarti I. Functional outcome after surgery for Dupuytren's contracture: a prospective study. J Hand Surg [Am]. Sep 2004;29(5):804-8. [Medline].

49. Fitzgerald AM, Kirkpatrick JJ, Naylor IL. Dupuytren's disease. The way forward?. J Hand Surg [Br]. Aug 1999;24(4):395-9. [Medline].

50. Hindocha S, Stanley JK, Watson S, Bayat A. Dupuytren's diathesis revisited: Evaluation of prognostic indicators for risk of disease recurrence. J Hand Surg [Am]. Dec 2006;31(10):1626-34. [Medline].

51. Lubahn JD, Pollard M, Cooney T. Immunohistochemical evidence of nerve growth factor in Dupuytren's diseased palmar fascia. J Hand Surg [Am]. Mar 2007;32(3):337-42. [Medline].

52. Rayan GM. Clinical presentation and types of Dupuytren's disease. Hand Clin. Feb 1999;15(1):87-96, vii. [Medline].

53. Ross DC. Epidemiology of Dupuytren's disease. Hand Clin. Feb 1999;15(1):53-62, vi. [Medline].

54. Roush TF, Stern PJ. Results following surgery for recurrent Dupuytren's disease. J Hand Surg [Am]. Mar 2000;25(2):291-6. [Medline].

55. Saar JD, Grothaus PC. Dupuytren's disease: an overview. Plast Reconstr Surg. Jul 2000;106(1):125-34; quiz 135-6. [Medline].

56. Shaw RB Jr, Chong AK, Zhang A, Hentz VR, Chang J. Dupuytren's disease: history, diagnosis, and treatment. Plast Reconstr Surg. Sep 2007;120(3):44e-54e. [Medline].

57. Thurston AJ. Dupuytren's disease. J Bone Joint Surg Br. May 2003;85(4):469-77. [Medline].

58. Yi IS, Johnson G, Moneim MS. Etiology of Dupuytren's disease. Hand Clin. Feb 1999;15(1):43-51, vi. [Medline].

Further Reading

Clinical trials

• Effects of Steroid Injection With Percutaneous Needle Aponeurotomy in Dupuytren's Contracture
• Health-Related Quality of Life in Patients With Dupuytren's Disease
• Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease
• Splinting for Dupuytren's Contracture Release

Keywords

Dupuytren contracture, Dupuytren's disease, Dupuytren disease, Dupuytren's contracture, palmar fibromatosis, fibrosis of the palmar fascia, flexure contraction of the digits, proximal interphalangeal joint contracture, PIP joint contracture, PIP contracture, metacarpophalangeal joint contracture, MCP joint contracture, MCP contracture, palmar contracture

Contributor Information and Disclosures

Author

Felisa S Lewis, MD, Resident Physician, National Capital Consortium Dermatology Program, Walter Reed Army Medical Center
Felisa S Lewis, MD is a member of the following medical societies: American Academy of Dermatology, International Society of Dermatology, and Women's Dermatologic Society
Disclosure: Nothing to disclose.

Coauthor(s)

Theresa Dressler Conologue, DO, FAAD, Physician, Department of Dermatology, Geisinger Medical Center
Theresa Dressler Conologue, DO, FAAD is a member of the following medical societies: American Academy of Cosmetic Surgery, American Academy of Dermatology, and American Society for Laser Medicine and Surgery
Disclosure: Nothing to disclose.

Kristina Shaffer, MD, MPH, Consulting Staff, Department of Dermatology, Dermatology Consultants
Kristina Shaffer, MD, MPH is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

Medical Editor

Evan R Farmer, MD, Professor of Dermatology, Johns Hopkins University School of Medicine, Clinical Professor of Pathology, Virginia Commonwealth University School of Medicine; Consulting Staff, Department of Dermatology, Johns Hopkins Hospital, VCU Health Services
Evan R Farmer, MD is a member of the following medical societies: American Academy of Dermatology, American Dermatological Association, American Medical Association, American Society of Dermatopathology, and International Society of Dermatology
Disclosure: Nothing to disclose.

Pharmacy Editor

David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Director, Dermatology Residency Training Program, Scott and White Clinic
David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Managing Editor

Jeffrey J Miller, MD, Associate Professor of Dermatology, Penn State University College of Medicine; Staff Dermatologist, Penn State Milton S Hershey Medical Center
Jeffrey J Miller, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, Association of Professors of Dermatology, North American Hair Research Society, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.

CME Editor

Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University
Catherine Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.